InhaTarget Therapeutics
Leuven, Belgium· Est. 2019
Inhatarget Therapeutics develops targeted inhalation formulations to improve treatment for severe respiratory diseases, with a first focus on lung cancer.
Private Company
Funding information not available
About
Inhatarget Therapeutics develops targeted inhalation formulations to improve treatment for severe respiratory diseases, with a first focus on lung cancer.
Drug Delivery